PFIZER Stock Overview
Engages in manufacturing, marketing, trading, and export of pharmaceutical products in India and internationally.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 1/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 3/6 |
Pfizer Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹5,921.45 |
52 Week High | ₹6,088.95 |
52 Week Low | ₹3,800.10 |
Beta | 0.30 |
11 Month Change | 14.06% |
3 Month Change | 31.48% |
1 Year Change | 53.61% |
33 Year Change | 3.98% |
5 Year Change | 104.22% |
Change since IPO | 320.41% |
Recent News & Updates
Recent updates
Subdued Growth No Barrier To Pfizer Limited (NSE:PFIZER) With Shares Advancing 25%
Aug 07Weak Statutory Earnings May Not Tell The Whole Story For Pfizer (NSE:PFIZER)
May 25Pfizer (NSE:PFIZER) Has A Pretty Healthy Balance Sheet
Feb 13Pfizer Limited's (NSE:PFIZER) Business Is Yet to Catch Up With Its Share Price
Jan 17Here's Why Pfizer (NSE:PFIZER) Can Manage Its Debt Responsibly
Mar 15A Look At The Intrinsic Value Of Pfizer Limited (NSE:PFIZER)
Jul 20Pfizer (NSE:PFIZER) Could Easily Take On More Debt
Mar 29Calculating The Fair Value Of Pfizer Limited (NSE:PFIZER)
Feb 07These 4 Measures Indicate That Pfizer (NSE:PFIZER) Is Using Debt Safely
Sep 23This Is The Reason Why We Think Pfizer Limited's (NSE:PFIZER) CEO Deserves A Bump Up To Their Compensation
Aug 12Are Institutions Heavily Invested In Pfizer Limited's (NSE:PFIZER) Shares?
Mar 10Why Dividend Hunters Love Pfizer Limited (NSE:PFIZER)
Feb 17Are Pfizer's (NSE:PFIZER) Statutory Earnings A Good Guide To Its Underlying Profitability?
Feb 02Need To Know: Pfizer Limited (NSE:PFIZER) Insiders Have Been Buying Shares
Jan 18Is Pfizer Limited's (NSE:PFIZER) Stock's Recent Performance A Reflection Of Its Financial Health?
Jan 03What Can We Learn About Pfizer's (NSE:PFIZER) CEO Compensation?
Dec 18Shareholder Returns
PFIZER | IN Pharmaceuticals | IN Market | |
---|---|---|---|
7D | 2.6% | 2.9% | 3.4% |
1Y | 53.6% | 54.2% | 44.3% |
Return vs Industry: PFIZER matched the Indian Pharmaceuticals industry which returned 54.2% over the past year.
Return vs Market: PFIZER exceeded the Indian Market which returned 44.3% over the past year.
Price Volatility
PFIZER volatility | |
---|---|
PFIZER Average Weekly Movement | 3.8% |
Pharmaceuticals Industry Average Movement | 6.3% |
Market Average Movement | 6.8% |
10% most volatile stocks in IN Market | 9.7% |
10% least volatile stocks in IN Market | 4.4% |
Stable Share Price: PFIZER's share price has been volatile over the past 3 months.
Volatility Over Time: PFIZER's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1950 | 1,721 | Meenakshi Nevatia | www.pfizerltd.co.in |
Pfizer Limited engages in manufacturing, marketing, trading, and export of pharmaceutical products in India and internationally. It offers its products in various therapeutic areas, including neuro/CNS, hormones, cardiovascular, haemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastro intestinal, vaccines, and respiratory, as well as vitamins, minerals, and nutrients. The company also offers internal medicine and anti-infectives services to hospitals and nursing homes.
Pfizer Limited Fundamentals Summary
PFIZER fundamental statistics | |
---|---|
Market cap | ₹270.89b |
Earnings (TTM) | ₹6.09b |
Revenue (TTM) | ₹22.25b |
44.5x
P/E Ratio12.2x
P/S RatioIs PFIZER overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PFIZER income statement (TTM) | |
---|---|
Revenue | ₹22.25b |
Cost of Revenue | ₹7.77b |
Gross Profit | ₹14.47b |
Other Expenses | ₹8.39b |
Earnings | ₹6.09b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 14, 2024
Earnings per share (EPS) | 133.01 |
Gross Margin | 65.06% |
Net Profit Margin | 27.35% |
Debt/Equity Ratio | 2.6% |
How did PFIZER perform over the long term?
See historical performance and comparison